Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

Sanofi (SAN) - Financial and Strategic SWOT Analysis Review


Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sanofi is a healthcare company, which is engaged in the discovery, development, manufacturing, and marketing of a wide range of medicines and vaccines. Its portfolio includes medicines for the treatment of cancer, rare diseases, multiple sclerosis; human vaccines for protection against various bacterial and viral diseases; and other products. The company also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals, and supplements. Sanofi's R&D efforts focus on advancing a combination drug to increase the effectiveness of treatments and on advancing the formulation of new biologics to produce precision medicines. It has operations in Europe, the Americas, Africa, Asia-Pacific, and the Middle East. Sanofi is headquartered in Paris, Ile-de-France, France.

Sanofi Key Recent Developments

Sep 10,2024: Vir Biotechnology closes Sanofi licence deal for T-cell engagers
Aug 26,2024: New Data Highlight Sanofi’s Scientific Innovation and Leadership in Immune-Mediated Respiratory Diseases
Jul 25,2024: Sanofi Q2 - Strong Performance with 10% Sales Growth; 2024 Guidance Upgraded
Jul 17,2024: Sanofi Announces Expansion of Its Global Capacity Centre In Hyderabad

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Sanofi - Key Facts
Sanofi - Key Employees
Sanofi - Key Employee Biographies
Sanofi - Major Products and Services
Sanofi - History
Sanofi - Company Statement
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 – Company Analysis
Company Overview
Sanofi - Business Description
Business Segment: Biopharma
Overview
Performance
Business Segment: Consumer Healthcare
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Sanofi - Corporate Strategy
Sanofi - SWOT Analysis
SWOT Analysis - Overview
Sanofi - Strengths
Sanofi - Weaknesses
Sanofi - Opportunities
Sanofi - Threats
Sanofi - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Sanofi, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 10, 2024: Vir Biotechnology closes Sanofi licence deal for T-cell engagers
Aug 26, 2024: New Data Highlight Sanofi’s Scientific Innovation and Leadership in Immune-Mediated Respiratory Diseases
Jul 25, 2024: Sanofi Q2 - Strong Performance with 10% Sales Growth; 2024 Guidance Upgraded
Jul 17, 2024: Sanofi Announces Expansion of Its Global Capacity Centre In Hyderabad
Jul 10, 2024: Sanofi Ships U.S. Influenza Vaccines for the 2024/25 Season
Jun 26, 2024: CTIBIOTECH Receives Prestigious Sanofi iDEA-TECH Award and France 2030 Awards to Launch Groundbreaking 1 million Euros SAFESKIN3D Bioprinting Project to Revolutionize Vaccine Safety Testing
Jun 26, 2024: EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
Jun 11, 2024: Benchling Builds Digital Data Foundation Powering Sanofi AI-Driven R&D
Jun 04, 2024: Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
May 30, 2024: Sanofi Opens New Advanced Vaccines Facility, Strengthening Its Commitment to Biomanufacturing in Canada
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Sanofi, Key Facts
Sanofi, Key Employees
Sanofi, Key Employee Biographies
Sanofi, Major Products and Services
Sanofi, History
Sanofi, Other Locations
Sanofi, Subsidiaries
Sanofi, Affiliate
Sanofi, Joint Venture
Sanofi, Key Competitors
Sanofi, Ratios based on current share price
Sanofi, Annual Ratios
Sanofi, Annual Ratios (Cont...1)
Sanofi, Annual Ratios (Cont...2)
Sanofi, Interim Ratios
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Sanofi, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sanofi, Performance Chart (2019 - 2023)
Sanofi, Ratio Charts
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings